About this trial
Monitoring the Use of Collagen Dura Regeneration Membrane - Repair (DMR) in the Post-market Phase.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with a dural defect requiring repair with a dural substitute as per routine clinical practice
Patient is 18 years or older
Patient of child-bearing potential is not pregnant or nursing
Participant is willing and able to provide consent
Disqualifiers
Patients with a known history of hypersensitivity to bovine derived materials
Patients that are non-English speaking
Patients requiring legal representation
Trial population
All patients with a dural defect requiring repair with a dural substitute.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Rate of Revision Surgery
Rate of adverse events related to the Subject Device requiring surgical intervention.
Secondary outcomes
Rate of Adverse Events
Intra-operative and post-operative adverse events (i.e., infection, CSF Leak, and Pseudomeningocele)
Product Performance
Score of adequacy of product performance - 1 (poor) to 4 (excellent)
Product Handling at Implantation
Score for product handling at implantation - 1 (poor) to 4 (excellent)
Product Adaptability at Implantation
Score for product adaptability at implantation - 1 (poor) to 4 (excellent)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Collagen Matrix
Lead sponsor
Stryker Nordic
Collaborator
This trial is not recruiting at the moment. You can still explore other options: